Aurelius SE & Co. KGaA

M&A Activity • Apr 4, 2012

News Details

Corporate | 4 April 2012 12:31

AURELIUS acquires Norwich manufacturing site from Bayer CropScience

AURELIUS AG / Key word(s): Acquisition

04.04.2012 / 12:31

---

AURELIUS acquires Norwich manufacturing site from Bayer CropScience

– Further acquisition in Specialty Chemicals business unit

– Third acquisition by AURELIUS this year

Munich, April 4, 2012 – The Munich-based AURELIUS Group (ISIN: DE000A0JK2A8) has agreed to acquire the manufacturing site in Norwich, United Kingdom from Bayer CropScience, a subgroup of Bayer AG. The 260 employees at the site in Norwich manufacture and formulate crop protection products for the global market and specialty industrial chemicals. Closing of the agreement is expected in the third quarter of 2012. Financial details were not disclosed.

The purchase of the Norwich site is part of AURELIUS' plans to concentrate on extending its product portfolio and expanding contract production for third-party customers, as well as exploiting the marketing expertise of existing affiliates in the specialty chemicals area. In addition, AURELIUS is planning to safeguard the long-term future viability of the site by investing in a waste water treatment plant and a multi-production facility. Following the acquisition, the Norwich site will operate under a new name in future.

'Specialty chemicals are one of our main priorities. The site in Norwich is in outstanding technical condition and a leader in its field. We believe that it has great potential for the future,' said Donatus Albrecht, member of the Board of Management of AURELIUS AG. 'We are delighted that with Bayer CropScience another well-known company has decided to sell part of its manufacturing activities to AURELIUS.'

The divestment of the production site in Norwich is part of Bayer CropScience's global consolidation of manufacturing of crop protection products.

**About AURELIUS

**The AURELIUS Group specializes in acquiring companies with development potential and providing them with operational support. With respect to the acquisition of subsidiaries, AURELIUS strives to identify, analyze, develop and exploit all available opportunities in the market. The AURELIUS Group understands itself to be a GOOD HOME for its subsidiaries on a long-term basis. Although its acquisition activities are not limited to a certain sector, AURELIUS has placed a certain emphasis on the following sectors: industrial enterprises, chemicals, business services, consumer goods/food & beverage and telecommunications, media & technology.

AURELIUS has many years of investment and management experience in different industries and sectors. AURELIUS improves the performance of its subsidiaries by providing management capacities and the necessary financial resources for investing in innovative products, sales and research. AURELIUS is a globally active company with offices in Munich and London and subsidiaries in Germany, Great Britain, France, Poland, Hungary, the Netherlands, Switzerland, Norway, Slovakia and Slovenia, as well as China and Malaysia. The shares of AURELIUS AG are traded in the Open Market segment of the Frankfurt Stock Exchange under ISIN DE000A0JK2A8. Additional information can be found at www.aureliusinvest.de .

Contact

Investor Relations & Corporate Communications

Phone +49 (89) 544799 – 0

Fax +49 (89) 544799 – 55

investor@aureliusinvest.de

End of Corporate News

---

04.04.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

163898  04.04.2012